More reads

• A Supreme Court ruling may have made it harder to get some info from the FDA. (STAT Plus)
• Chinese VC spending on U.S. biotech hit by security reviews. (Financial Times)
• Stem cell funding agency CIRM is nearly out of funds. (The Scientist)